Patient enrollment is complete in a Phase 3 trial testing a new formulation of Briumvi (ublituximab-xiiy), TG Therapeutics‘Â multiple sclerosis (MS) medication for relapsing forms of the disease, that could be injected at home. The new formulation is designed to be given under the skin, or subcutaneously, every…
Discussion
In multiple sclerosis (MS), mindfulness may increase the time a patient spends asleep while in bed, but physical activity appears to have small and inconsistent benefits on sleep. That’s according to a meta-analysis of five published studies that looked at the impact of interventions designed to improve sleep among…
Discussion
I would say that no one grows up telling themselves that they can’t wait to get their first minivan, but that’s probably just my opinion. I will allow for the possibility that some people have thought that exact thing, but I never did. As I imagine is the case for…
Discussion
A new formulation — a film that dissolves under the tongue — of cladribine for treating multiple sclerosis (MS) has moved closer to clinical testing, according to an update from its developer. Bionxt Solutions announced that it has completed manufacturing of a clinical-grade batch of BNT23001, its…
Discussion
Using disease-modifying treatments shortly prior to or during pregnancy does not seem to increase the risk of neurodevelopmental disorders in exposed children, according to a real-world study of mothers with multiple sclerosis (MS). Still, sphingosine-1-phosphate (S1P) receptor modulators, which include therapies such as Gilenya (fingolimod), Mayzent…
Get regular updates to your inbox.
